Susquehanna Fundamental Investments’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,680
| Closed | -$370K | – | 1834 |
|
|
2021
Q3 | $370K | Sell |
3,680
-7,250
| -66% | -$729K | 0.01% | 1328 |
|
|
2021
Q2 | $1.55M | Buy |
+10,930
| New | +$1.55M | 0.03% | 689 |
|
|
2021
Q1 | – | Sell |
-27,340
| Closed | -$3.38M | – | 1651 |
|
|
2020
Q4 | $3.38M | Buy |
27,340
+17,540
| +179% | +$2.17M | 0.06% | 455 |
|
|
2020
Q3 | $955K | Buy |
9,800
+1,700
| +21% | +$166K | 0.03% | 657 |
|
|
2020
Q2 | $1.26M | Buy |
+8,100
| New | +$1.26M | 0.06% | 394 |
|